These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20145061)

  • 21. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.
    Tung R; Zimetbaum P; Josephson ME
    J Am Coll Cardiol; 2008 Sep; 52(14):1111-21. PubMed ID: 18804736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
    Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
    Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary prevention of sudden cardiac death: indications for cardioverter-defibrillator implantation.
    Botto GL; Proclemer A; Luzi M; Ruffa F; Gorgoglione MG; Ferrari G
    Ital Heart J; 2005 Mar; 6(3):210-5. PubMed ID: 15875511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost of implantable defibrillators: perceptions and reality.
    Camm J; Klein H; Nisam S
    Eur Heart J; 2007 Feb; 28(4):392-7. PubMed ID: 16887857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventing sudden death: implantable cardioverter-defibrillators in elderly cardiac patients.
    Groeneveld PW
    LDI Issue Brief; 2008; 13(6):1-4. PubMed ID: 18613344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable cardioverter defibrillators: an excellent case study.
    Stanton MS
    Health Aff (Millwood); 2005; 24(1):52-4. PubMed ID: 15647215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of renal dysfunction on appropriate therapy in implantable cardioverter defibrillator patients with non-ischaemic dilated cardiomyopathy.
    Takahashi A; Shiga T; Shoda M; Manaka T; Ejima K; Hagiwara N
    Europace; 2009 Nov; 11(11):1476-82. PubMed ID: 19661116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death.
    Henyan NN; White CM; Gillespie EL; Smith K; Coleman CI; Kluger J
    J Intern Med; 2006 Nov; 260(5):467-73. PubMed ID: 17040253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology.
    Hauer RN; Aliot E; Block M; Capucci A; Lüderitz B; Santini M; Vardas PE;
    Eur Heart J; 2001 Jul; 22(13):1074-81. PubMed ID: 11428848
    [No Abstract]   [Full Text] [Related]  

  • 32. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials.
    Nanthakumar K; Epstein AE; Kay GN; Plumb VJ; Lee DS
    J Am Coll Cardiol; 2004 Dec; 44(11):2166-72. PubMed ID: 15582314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence of ventricular arrhythmias in patients with non-ischaemic dilated cardiomyopathy: evidence-based predictors.
    Dułak E; Lubiński A; Bissinger A; Przybylski A; Sterlinski M; Filipecki A; Pazdyga A; Zienciuk A; Kempa M; Królak T; Szwed H; Trusz-Gluza M; Kargul W
    Kardiol Pol; 2009 Aug; 67(8):837-44. PubMed ID: 19784881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of the implantable cardioverter defibrillator.
    Hlatky MA; Sanders GD; Owens DK
    Card Electrophysiol Rev; 2003 Dec; 7(4):479-82. PubMed ID: 15071279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The incidence of implantable cardioverter defibrillator indications in patients admitted to all coronary care units in a single district.
    Plummer CJ; John Irving R; McComb JM
    Europace; 2005 May; 7(3):266-72. PubMed ID: 15878566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
    Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic implantable cardioverter defibrillator therapy in dilated cardiomyopathy: impact of left ventricular function.
    Schaer BA; Ammann P; Sticherling C; Zellweger MJ; Cron TA; Osswald S
    Int J Cardiol; 2006 Mar; 108(1):26-30. PubMed ID: 16516695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy.
    Goldberger JJ; Subacius H; Schaechter A; Howard A; Berger R; Shalaby A; Levine J; Kadish AH;
    J Am Coll Cardiol; 2006 Sep; 48(6):1228-33. PubMed ID: 16979011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.